skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ScienceDirect remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Planchard, D ; Popat, S ; Kerr, K ; Novello, S ; Smit, E F ; Faivre-Finn, C ; Mok, T S ; Reck, M ; Van Schil, P E ; Hellmann, M D ; Peters, S

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv192-iv237 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
2
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

Osorio, J.C. ; Ni, A. ; Chaft, J.E. ; Pollina, R. ; Kasler, M.K. ; Stephens, D. ; Rodriguez, C. ; Cambridge, L. ; Rizvi, H. ; Wolchok, J.D. ; Merghoub, T. ; Rudin, C.M. ; Fish, S. ; Hellmann, M.D.

Annals of oncology, 2017-03, Vol.28 (3), p.583-589 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
Material Type:
Artigo 		Adicionar ao Meu Espaço

Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Yu, H.A. ; Arcila, M.E. ; Hellmann, M.D. ; Kris, M.G. ; Ladanyi, M. ; Riely, G.J.

Annals of oncology, 2014-02, Vol.25 (2), p.423-428 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer

Peters, S. ; Reck, M. ; Smit, E.F. ; Mok, T. ; Hellmann, M.D.

Annals of oncology, 2019-06, Vol.30 (6), p.884-896 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib

Schoenfeld, A.J. ; Arbour, K.C. ; Rizvi, H. ; Iqbal, A.N. ; Gadgeel, S.M. ; Girshman, J. ; Kris, M.G. ; Riely, G.J. ; Yu, H.A. ; Hellmann, M.D.

Annals of oncology, 2019-05, Vol.30 (5), p.839-844 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

Derosa, L. ; Hellmann, M.D. ; Spaziano, M. ; Halpenny, D. ; Fidelle, M. ; Rizvi, H. ; Long, N. ; Plodkowski, A.J. ; Arbour, K.C. ; Chaft, J.E. ; Rouche, J.A. ; Zitvogel, L. ; Zalcman, G. ; Albiges, L. ; Escudier, B. ; Routy, B.

Annals of oncology, 2018-06, Vol.29 (6), p.1437-1444 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

Belum, V.R ; Benhuri, B ; Postow, M.A ; Hellmann, M.D ; Lesokhin, A.M ; Segal, N.H ; Motzer, R.J ; Wu, S ; Busam, K.J ; Wolchok, J.D ; Lacouture, M.E

European journal of cancer (1990), 2016-06, Vol.60, p.12-25 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Hastings, K. ; Yu, H.A. ; Wei, W. ; Sanchez-Vega, F. ; DeVeaux, M. ; Choi, J. ; Rizvi, H. ; Lisberg, A. ; Truini, A. ; Lydon, C.A. ; Liu, Z. ; Henick, B.S. ; Wurtz, A. ; Cai, G. ; Plodkowski, A.J. ; Long, N.M. ; Halpenny, D.F. ; Killam, J. ; Oliva, I. ; Schultz, N. ; Riely, G.J. ; Arcila, M.E. ; Ladanyi, M. ; Zelterman, D. ; Herbst, R.S. ; Goldberg, S.B. ; Awad, M.M. ; Garon, E.B. ; Gettinger, S. ; Hellmann, M.D. ; Politi, K.

Annals of oncology, 2019-08, Vol.30 (8), p.1311-1320 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

Schoenfeld, A.J. ; Rizvi, H. ; Bandlamudi, C. ; Sauter, J.L. ; Travis, W.D. ; Rekhtman, N. ; Plodkowski, A.J. ; Perez-Johnston, R. ; Sawan, P. ; Beras, A. ; Egger, J.V. ; Ladanyi, M. ; Arbour, K.C. ; Rudin, C.M. ; Riely, G.J. ; Taylor, B.S. ; Donoghue, M.T.A. ; Hellmann, M.D.

Annals of oncology, 2020-05, Vol.31 (5), p.599-608 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

Aguilar, E.J. ; Ricciuti, B. ; Gainor, J.F. ; Kehl, K.L. ; Kravets, S. ; Dahlberg, S. ; Nishino, M. ; Sholl, L.M. ; Adeni, A. ; Subegdjo, S. ; Khosrowjerdi, S. ; Peterson, R.M. ; Digumarthy, S. ; Liu, C. ; Sauter, J. ; Rizvi, H. ; Arbour, K.C. ; Carter, B.W. ; Heymach, J.V. ; Altan, M. ; Hellmann, M.D. ; Awad, M.M.

Annals of oncology, 2019-10, Vol.30 (10), p.1653-1659 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (430)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (442)
  2. Anais de Congresso  (5)
  3. Reports  (1)
  4. Book Chapters  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1986  (21)
  2. 1986Até1994  (47)
  3. 1995Até2003  (72)
  4. 2004Até2013  (111)
  5. Após 2013  (199)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (438)
  2. Japonês  (38)
  3. Francês  (7)
  4. Russo  (5)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.